Sponsor of the Day:
Jerkmate
https://pubmed.ncbi.nlm.nih.gov/41212559/
Paternal Valproate Use and Neurodevelopmental Disorder and Congenital Malformation Risk in...
In this cohort study, higher NDD risk was observed in offspring paternally exposed to valproate vs lamotrigine or levetiracetam, but no difference in CM risk...
neurodevelopmental disorderpaternalvalproateusecongenital
https://nhpc.ie/update/valproate-epilim-important-safety-information-from-sanofi-aventis/
Valproate (Epilim) – Important Safety Information from Sanofi-Aventis - National Healthcare Product...
important safety informationnational healthcare productvalproatesanofiaventis
https://www.nhs.uk/medicines/sodium-valproate/
Sodium valproate: medicine used for epilepsy, bipolar disorder and migraine - NHS
Jun 17, 2025 - NHS medicines information on sodium valproate – what it's used for, side effects, dosage and who can take it.
medicine usedbipolar disordermigraine nhssodiumvalproate
https://www.nami.org/treatments-and-approaches/mental-health-medications/types-of-medication/valproate-depakote/
Valproate (Depakote) | NAMI
Nov 14, 2025 - Valproate (Depakote) is a mood stabilizer medication that works in the brain. It is approved for the treatment of mania associated with bipolar disorder (also...
valproatedepakotenami
https://www.sanofi.com/en/our-company/sustainability/responsible-business-values/sodium-valproate
Information on Sodium Valproate
Stay updated with the latest information on Sodium Valproate (Depakine) from Sanofi. Download safety studies, regulatory statements, and more.
informationsodiumvalproate